Jeffrey Williamson MD in Springfield, Illinois

Medical School: Illinois Medical College
Graduation Year: 1980
The Primary Medical Specialty for Jeffrey Williamson MD is listed as: Colorectal Surgery (proctology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 44
PAC (PECOS ID)#: 7012995384
NPI #: 1154302602
NPI Created On: 11/10/2005
NPI Last Updated Listed as: 03/30/2011
Primary Taxonomy Code: 208600000X
License Number:
036066240
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Removal of polyps or growths in large bowel using an endoscope
2. Removal of hemorrhoid by rubber banding
3. New patient office or other outpatient visit, typically 20 minutes
4. New patient office or other outpatient visit, typically 30 minutes
5. Established patient office or other outpatient visit, typically 10 minutes
6. Established patient office or other outpatient visit, typically 15 minutes
7. Established patient office or other outpatient, visit typically 25 minutes
8. Initial hospital inpatient care, typically 50 minutes per day
9. Initial hospital inpatient care, typically 70 minutes per day
10. Subsequent hospital inpatient care, typically 15 minutes per day
11. Subsequent hospital inpatient care, typically 25 minutes per day
12. Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.